| 2021 | Angiotensin receptor-neprilysin inhibitor in patients with heart failure and chronic kidney disease | 조인정 | Review |
| 2022 | Association between exposure to fine particulate matter and kidney function: Results from the Korea National Health and Nutrition Examination Survey | 하은희; 강덕희 | Article |
| 2022 | Benefit and risk of prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with chronic kidney disease: A nationwide cohort study | 김충기 | Article |
| 2017 | Blood pressure control during chronic kidney disease progression | 이외숙; 하은희; 강덕희; 최규복; 김승정; 류동열; 이은경; 오형중 | Article |
| 2016 | Changes in serum metabolites with the stage of chronic kidney disease: Comparison of diabetes and non-diabetes | 황금숙 | Article |
| 2021 | Combined application of rapamycin and atorvastatin improves lipid metabolism in apolipoprotein E-deficient mice with chronic kidney disease | 오구택 | Article |
| 2021 | Comparison of Different Types of Oral Adsorbent Therapy in Patients with Chronic Kidney Disease: A Multicenter, Randomized, Phase IV Clinical Trial | 강덕희 | Article |
| 2020 | Discrepant glomerular filtration rate trends from creatinine and cystatin C in patients with chronic kidney disease: results from the KNOW-CKD cohort | 강은정 | Article |
| 2021 | Dual actions of a2a and a3 adenosine receptor ligand prevents obstruction-induced kidney fibrosis in mice | 하헌주 | Article |
| 2017 | Economic burden of chronic kidney disease in Korea using national sample cohort | 류동열 | Article |
| 2020 | Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Heart Failure With Chronic Kidney Disease - Propensity Score Matching Analysis - | 김경진 | Article |
| 2022 | Exercise reduces the risk of chronic kidney disease in individuals with nonalcoholic fatty liver disease: A nationwide cohort study | 이민종; 전호수 | Article |
| 2017 | FimAsartaN proTeinuriA SusTaIned reduCtion in comparison with losartan in diabetic chronic kidney disease (FANTASTIC): study protocol for randomized controlled trial | 류동열 | Article |
| 2021 | Hyperuricemia is a risk factor for the progression to end-stage renal disease in minimal change disease | 류동열 | Article |
| 2021 | KF-1607, a Novel Pan Src Kinase Inhibitor, Attenuates Obstruction-Induced Tubulointerstitial Fibrosis in Mice | 하헌주 | Article |
| 2021 | Metformin use and cardiovascular outcomes in patients with diabetes and chronic kidney disease: a nationwide cohort study | 류동열 | Article |
| 2020 | Noninvasive indices for predicting nonalcoholic fatty liver disease in patients with chronic kidney disease | 유권; 이정경; 김태헌; 류동열; 김휘영; 임지영; 김진실; 이혜아 | Article |
| 2019 | Physicians’ perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey | 강덕희 | Article |
| 2022 | Renoprotective Effects of Mangiferin: Pharmacological Advances and Future Perspectives | Md Jamal Uddin | Review |
| 2021 | Serum uric acid is associated with coronary artery calcification in early chronic kidney disease: a cross-sectional study | 강은정 | Article |
| 2020 | The Combined Impact of Chronic Kidney Disease and Diabetes on the Risk of Colorectal Cancer Depends on Sex: A Nationwide Population-Based Study | 류동열; 문창모; 오형중; 이혜아 | Article |
| 2015 | Time points for obtaining representative values of 24-hour blood pressure in chronic kidney disease | 류동열 | Article |
| 2014 | Uric Acid Metabolism and the Kidney | 강덕희 | Book Chapter |
